vs
Pediatrix Medical Group, Inc.（MD）とUSA Compression Partners, LP（USAC）の財務データ比較。上の社名をクリックして会社を切り替えられます
Pediatrix Medical Group, Inc.の直近四半期売上が大きい（$493.8M vs $252.5M、USA Compression Partners, LPの約2.0倍）。USA Compression Partners, LPの純利益率が高く（11.0% vs 6.8%、差は4.2%）。USA Compression Partners, LPの前年同期比売上増加率が高い（2.7% vs -1.7%）。過去8四半期でUSA Compression Partners, LPの売上複合成長率が高い（4.9% vs -0.1%）
Pediatrix Medical Group, Inc.は米国を代表する専門医療サービスプロバイダーで、母胎医療、新生児科、小児心臓病学などの小児亜専門を中心に事業を展開し、米国全土の医療機関と提携して女性、新生児、子どもに根拠に基づく質の高い医療を提供しています。
USA Compression Partners, LPは米国に本拠を置く天然ガス圧縮サービスプロバイダーであり、石油・ガス業界の上流・中流・下流分野の顧客向けに、カスタム圧縮システム、保守サービス、運用支援を提供し、天然ガスの生産・加工・輸送の効率化を支えています。
MD vs USAC — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $493.8M | $252.5M |
| 純利益 | $33.7M | $27.8M |
| 粗利率 | — | — |
| 営業利益率 | 9.9% | 30.3% |
| 純利益率 | 6.8% | 11.0% |
| 売上前年比 | -1.7% | 2.7% |
| 純利益前年比 | 10.5% | 9.1% |
| EPS（希薄化後） | $0.40 | — |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $493.8M | $252.5M | ||
| Q3 25 | $492.9M | $250.3M | ||
| Q2 25 | $468.8M | $250.1M | ||
| Q1 25 | $458.4M | $245.2M | ||
| Q4 24 | $502.4M | $245.9M | ||
| Q3 24 | $511.2M | $240.0M | ||
| Q2 24 | $504.3M | $235.3M | ||
| Q1 24 | $495.1M | $229.3M |
| Q4 25 | $33.7M | $27.8M | ||
| Q3 25 | $71.7M | $34.5M | ||
| Q2 25 | $39.3M | $28.6M | ||
| Q1 25 | $20.7M | $20.5M | ||
| Q4 24 | $30.5M | $25.4M | ||
| Q3 24 | $19.4M | $19.3M | ||
| Q2 24 | $-153.0M | $31.2M | ||
| Q1 24 | $4.0M | $23.6M |
| Q4 25 | 9.9% | 30.3% | ||
| Q3 25 | 13.8% | 33.5% | ||
| Q2 25 | 12.8% | 30.6% | ||
| Q1 25 | 7.0% | 28.3% | ||
| Q4 24 | 7.8% | 30.3% | ||
| Q3 24 | 6.6% | 31.5% | ||
| Q2 24 | -31.3% | 32.9% | ||
| Q1 24 | 3.2% | 29.2% |
| Q4 25 | 6.8% | 11.0% | ||
| Q3 25 | 14.5% | 13.8% | ||
| Q2 25 | 8.4% | 11.4% | ||
| Q1 25 | 4.5% | 8.4% | ||
| Q4 24 | 6.1% | 10.3% | ||
| Q3 24 | 3.8% | 8.1% | ||
| Q2 24 | -30.3% | 13.3% | ||
| Q1 24 | 0.8% | 10.3% |
| Q4 25 | $0.40 | — | ||
| Q3 25 | $0.84 | — | ||
| Q2 25 | $0.46 | — | ||
| Q1 25 | $0.24 | — | ||
| Q4 24 | $0.37 | — | ||
| Q3 24 | $0.23 | — | ||
| Q2 24 | $-1.84 | — | ||
| Q1 24 | $0.05 | — |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $375.2M | $8.6M |
| 総負債低いほど良い | $570.5M | $2.5B |
| 株主資本純資産 | $865.9M | — |
| 総資産 | $2.2B | $2.6B |
| 負債/資本比率低いほどレバレッジが低い | 0.66× | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $375.2M | $8.6M | ||
| Q3 25 | $340.1M | — | ||
| Q2 25 | $224.7M | $2.0K | ||
| Q1 25 | $99.0M | $2.0K | ||
| Q4 24 | $229.9M | $14.0K | ||
| Q3 24 | $103.8M | $79.0K | ||
| Q2 24 | $19.4M | $9.0K | ||
| Q1 24 | $8.0M | $8.0K |
| Q4 25 | $570.5M | $2.5B | ||
| Q3 25 | $577.2M | $2.5B | ||
| Q2 25 | $583.9M | $2.5B | ||
| Q1 25 | $590.5M | $2.5B | ||
| Q4 24 | $597.1M | $2.5B | ||
| Q3 24 | — | $2.5B | ||
| Q2 24 | — | $2.5B | ||
| Q1 24 | — | $2.5B |
| Q4 25 | $865.9M | — | ||
| Q3 25 | $890.7M | — | ||
| Q2 25 | $833.8M | — | ||
| Q1 25 | $789.2M | — | ||
| Q4 24 | $764.9M | — | ||
| Q3 24 | $732.5M | — | ||
| Q2 24 | $706.5M | — | ||
| Q1 24 | $856.2M | — |
| Q4 25 | $2.2B | $2.6B | ||
| Q3 25 | $2.2B | $2.7B | ||
| Q2 25 | $2.1B | $2.7B | ||
| Q1 25 | $2.0B | $2.7B | ||
| Q4 24 | $2.2B | $2.7B | ||
| Q3 24 | $2.1B | $2.8B | ||
| Q2 24 | $2.0B | $2.8B | ||
| Q1 24 | $2.2B | $2.8B |
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $114.1M | $139.5M |
| フリーキャッシュフロー営業CF - 設備投資 | — | $87.7M |
| FCFマージンFCF / 売上 | — | 34.8% |
| 設備投資強度設備投資 / 売上 | — | 20.5% |
| キャッシュ転換率営業CF / 純利益 | 3.39× | 5.02× |
| 直近12ヶ月FCF直近4四半期 | — | $277.0M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $114.1M | $139.5M | ||
| Q3 25 | $137.3M | $75.9M | ||
| Q2 25 | $137.2M | $124.2M | ||
| Q1 25 | $-117.5M | $54.7M | ||
| Q4 24 | $133.0M | $130.2M | ||
| Q3 24 | $91.8M | $48.5M | ||
| Q2 24 | $107.0M | $96.7M | ||
| Q1 24 | $-125.2M | $65.9M |
| Q4 25 | — | $87.7M | ||
| Q3 25 | — | $51.9M | ||
| Q2 25 | — | $101.1M | ||
| Q1 25 | — | $36.3M | ||
| Q4 24 | — | $101.2M | ||
| Q3 24 | — | $19.8M | ||
| Q2 24 | — | $48.2M | ||
| Q1 24 | — | $-32.7M |
| Q4 25 | — | 34.8% | ||
| Q3 25 | — | 20.7% | ||
| Q2 25 | — | 40.4% | ||
| Q1 25 | — | 14.8% | ||
| Q4 24 | — | 41.1% | ||
| Q3 24 | — | 8.2% | ||
| Q2 24 | — | 20.5% | ||
| Q1 24 | — | -14.3% |
| Q4 25 | — | 20.5% | ||
| Q3 25 | — | 9.6% | ||
| Q2 25 | — | 9.3% | ||
| Q1 25 | — | 7.5% | ||
| Q4 24 | — | 11.8% | ||
| Q3 24 | — | 12.0% | ||
| Q2 24 | — | 20.6% | ||
| Q1 24 | — | 43.0% |
| Q4 25 | 3.39× | 5.02× | ||
| Q3 25 | 1.91× | 2.20× | ||
| Q2 25 | 3.49× | 4.35× | ||
| Q1 25 | -5.66× | 2.66× | ||
| Q4 24 | 4.36× | 5.12× | ||
| Q3 24 | 4.72× | 2.51× | ||
| Q2 24 | — | 3.10× | ||
| Q1 24 | -31.03× | 2.80× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
USAC
| Revenue From Contract Operations Excluding Revenue From Related Party | $231.7M | 92% |
| Entities Affiliated With Energy Transfer LP | $16.6M | 7% |
| Transferred At Point In Time | $5.4M | 2% |
